Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, GeneInsight to Collaborate on Interpretation Software for Clinical Laboratories

Premium

Ingenuity Systems said this week that it is partnering with GeneInsight, a wholly owned subsidiary of Partners HealthCare, to develop an integrated workflow solution that will include tools for annotating, analyzing, assessing, and reporting human variants from next-generation sequencing-based tests.

Heidi Rehm, chief laboratory director of Partners' laboratory for molecular medicine, said in a statement that "the combined solution will incorporate knowledge about genomic variation from the Ingenuity offering with GeneInsight's knowledge management and reporting infrastructure, helping to streamline the overall workflow for very broad spectrum tests.”

Under the terms of the agreement, Ingenuity will provide content and software for the analysis and biological interpretation of variants from sequencing-based tests. GeneInsight will provide genetic testing laboratories and providers with networked infrastructure to support interpretation, reporting, and management of genetic data.

Additional details were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more